Recent Posts

Heading Annual Report
Introducing the 2023/24 Annual Impact Report
Herobannerpng
Kickstart 2025 by volunteering for Walk to Defeat MND
Brent Story 2024 Family Photo
Living with purpose: Brent’s journey with MND

Free webinar: the future of MND treatment in Aotearoa

Education

31 August 2023

Mhhwebinar214 1colmailchimp640

The future of MND treatment in New Zealand: Best practice recommendations and beyond

Wednesday 6 September, 2023
7pm – 8pm

Comprehensive, multidisciplinary care is the current gold standard for treating MND. Motor Neurone Disease NZ recently facilitated the production of best practice guidelines for the care of people living with motor neurone disease.  

Developed over a number of years by a working group of clinicians, this document represents what specialists in MND care agree should be the standard of care for any New Zealander diagnosed with MND.

In this webinar, Dr Alan Stanley will outline the principles behind providing the best possible care for people with MND, as well as exploring future avenues for MND treatment. 

Please note, this webinar is aimed at health professionals and members of multidisciplinary teams (MDT) who care for patients with MND, but everyone is welcome to attend.   

Join us on Wednesday 6 September from 7pm to 8pm and bring your questions for the interactive Q+A session.   
 

Meet the Presenter

Dr Alan Stanley
Consultant Neurologist, Te Whatu Ora – Hawkes Bay Te Matau-a-Maui, MBChB, FRACP

Alan currently works as a Consultant Neurologist in Hawke's Bay. He is the co-chair of the motor neurone disease (MND) best practice recommendations writing group and is a board member for Motor Neurone Disease NZ. He is actively involved in the clinical care of people living with MND and is interested in improving clinical care and access to clinical trials. He is the current Principal investigator of the Lighthouse 2 trial for treatment of MND.

  • Sign up to our newsletter and stay up to date

"*" indicates required fields

This field is for validation purposes and should be left unchanged.